MC: Novo Nordisk Phar-matech A/S has entered into an agreement with Signet Chemical Corpora-tion for the distribution of its pharmaceutical range of quaternary ammonium compounds (FEF Quats) to the healthcare industry in India, Bangladesh and Sri Lanka. Mr Shah, Managing director of Signet commented on this new collaboration. : “We are pleased to be associated with Novo Nordisk Pharmatech which is the leading supplier of Quats to the pharmaceutical and biopharmaceutical markets. Novo Nordisk Pharmatech’s FeF Quats complement our existing portfolio of excipients used especially for ophthalmic, nasal and topical dosage forms”.
Our time is a news portal